H.R. 254 · 117th Congress

Neuromyelitis Optica Spectrum Disorder Consortium Act

Stage
In committee
Introduced
2021-01-11
Latest action
2021-02-02 · Referred to the Subcommittee on Health.

Summary

Neuromyelitis Optica Spectrum Disorder Consortium Act

This bill requires the National Institutes of Health to establish a national consortium to coordinate and support research on neuromyelitis optica spectrum disorder, including by awarding grants. This is a neurological disease that can cause blindness, paralysis, and premature death.